IB Nimble vs HemOncBytes
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IB Nimble
Read full descriptionHide full description
IB Nimble provides access to a set of professionally recognized diagnostic algorithms for oncologic diseases. It also allows asynchronous communication between clinical experts, facilitating patient care. IB Nimble provides real-time, evidence-based treatment plans which can reduce length of hospital stay, costs, and care delays for a critical patient population. The smart technology embedded in IB Nimble enhances cancer treatment center capabilities and physicians' expertise to make healthcare more efficient, thus enhancing patient health and well-being.
HemOncBytes
Stay current with hematology and oncology information through concise, actionable updates. This app uses a microlearning and active recall method to boost clinical confidence and decision-making speed. Content is clinically relevant and vetted by practicing oncologists.
- Quick, actionable bytes of information
- Microlearning and active recall
- Clinically relevant content
- Vetted by practicing oncologists
- Boosts clinical confidence
- Practice-changing updates
Read full descriptionHide full description
Are you drowning in oncology information overload? There's a better way to stay current in oncology. HemOncBytes delivers core heme/onc knowledge + practice-changing updates in quick, actionable bytes. * Reclaim hours weekly * Boost clinical confidence * Make informed decisions, faster Learn smarter, not harder. Our unique Bytes Method combines microlearning with active recall, ensuring you not only learn faster but retain more. Created and vetted by practicing oncologists, every piece of content is clinically relevant, immediately applicable, and designed to help you make confident decisions at the point of care.
Screenshots
Verdict
The clearest difference is in-app purchases: IB Nimble at none against HemOncBytes's 1. IB Nimble also leads on iOS requirement (12.0 vs 15.2). On price, update cadence, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. HemOncBytes sells 1 one-off in-app purchase. IB Nimble asks for nothing beyond the download.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on September 19, 2026 and July 18, 2026 respectively.
| Parameter | IB Nimble | HemOncBytes |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (7 ratings) — better |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | — | 7 — better |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | — | Free with in-app purchases |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 15.2 |
| Further details — not scored | ||
| Size | 16 MB | 112 MB |
| Age rating | 12+ | 4+ |
| Developer | Imaging Biometrics, LLC | VitalFolio LLC |
In-app purchases
IB Nimble
No in-app purchases
HemOncBytes
- Best of ASCO 2025$100.00
